Thrivent Financial for Lutherans’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.39M | Sell |
|
|||||
|
2025
Q1 | $1.49M | Sell |
|
|||||
|
2024
Q4 | $1.71M | Sell |
|
|||||
|
2024
Q3 | $3.46M | Sell |
|
|||||
|
2024
Q2 | $107M | Sell |
|
|||||
|
2024
Q1 | $95.8M | Buy |
|
|||||
|
2023
Q4 | $69.5M | Buy |
|
|||||
|
2023
Q3 | $44.5M | Sell |
|
|||||
|
2023
Q2 | $47.3M | Sell |
|
|||||
|
2023
Q1 | $145M | Buy |
|
|||||
|
2022
Q4 | $85M | Sell |
|
|||||
|
2022
Q3 | $70.4M | Buy |
|
|||||
|
2022
Q2 | $84.6M | Sell |
|
|||||
|
2022
Q1 | $87.8M | Buy |
|
|||||
|
2017
Q4 | – | Sell |
|
|||||
|
2017
Q3 | $18K | Buy |
|